(2S,3S)-2-(3-((S)-3-amino-1-(5-((S)-1-amino-2-hydroxyethyl)-1,3,4-thiadiazol-2-yl)-3-oxopropyl)ureido)-3-hydroxybutanoic acid

ID: ALA4205401

Chembl Id: CHEMBL4205401

PubChem CID: 145975141

Max Phase: Preclinical

Molecular Formula: C12H20N6O6S

Molecular Weight: 376.40

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  C[C@H](O)[C@H](NC(=O)N[C@@H](CC(N)=O)c1nnc([C@@H](N)CO)s1)C(=O)O

Standard InChI:  InChI=1S/C12H20N6O6S/c1-4(20)8(11(22)23)16-12(24)15-6(2-7(14)21)10-18-17-9(25-10)5(13)3-19/h4-6,8,19-20H,2-3,13H2,1H3,(H2,14,21)(H,22,23)(H2,15,16,24)/t4-,5-,6-,8-/m0/s1

Standard InChI Key:  ZHZFEBZMBHOQIK-TYQACLPBSA-N

Alternative Forms

  1. Parent:

    ALA4205401

    ---

Associated Targets(Human)

PDCD1 Tclin Programmed cell death protein 1 (14 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 376.40Molecular Weight (Monoisotopic): 376.1165AlogP: -2.42#Rotatable Bonds: 9
Polar Surface Area: 213.78Molecular Species: ACIDHBA: 9HBD: 7
#RO5 Violations: 1HBA (Lipinski): 12HBD (Lipinski): 9#RO5 Violations (Lipinski): 2
CX Acidic pKa: 3.28CX Basic pKa: 6.84CX LogP: -6.35CX LogD: -6.93
Aromatic Rings: 1Heavy Atoms: 25QED Weighted: 0.24Np Likeness Score: -0.39

References

1. Toogood PL..  (2018)  Small molecule immuno-oncology therapeutic agents.,  28  (3): [PMID:29326017] [10.1016/j.bmcl.2017.12.044]

Source